Sally has 25 years’ experience as a senior leader in all aspects of research management across the charity, higher education and NHS sectors. She is a skilled facilitator of research, particularly translational and experimental medicine research, preclinical development and early clinical trials of novel treatments.
Currently, Sally is Director of the Lister Institute of Preventative Medicine. She is also a Research Fellow at the University of Sunderland developing a new treatment for cystinosis, a rare inherited disorder. She is a trustee for two charities – LifeArc and Trozon X17.
Previously, Sally has worked in a variety of senior research leadership and management roles in Norfolk and Norwich NHS Trust; Queen Mary University of London; Barts Health NHS Trust; and Imperial College London.
Prior to these roles, Sally worked in a variety of positions in Cancer Research UK including Director of Drug Development and Director of Centres. During her time at CRUK, Sally played a key role in taking over 50 novel agents into first in man Phase I trials, including Temodal®, Zytiga® and Rubraca®, all successful cancer drugs that now benefit patients worldwide.Back to our trustees